MAPT and Alzheimer disease: Thus, this study highlights uncertainty regarding the need to determine whether tau pathology is mainly driven by Aβ‐dependent or independent processes or whether Aβ and tau accumulation are independently associated with future cognitive decline in the AD continuum.